Search research articles
Contact Us
Filters
Showing results (11-20 of 48) with videos related to
Page
of 5
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
September 26, 1997
Peripheral blood progenitor cell transplantation in multiple myeloma following high-dose melphalan-based therapy
H Goldschmidt, U Hegenbart, M Wallmeier, et al.
Blood
|
October 15, 1994
Monocyte chemoattractant protein-1 gene is expressed in activated neutrophils and retinoic acid-induced human myeloid cell lines
T C Burn, M S Petrovick, S Hohaus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1997
High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma
H Goldschmidt, U Hegenbart, M Wallmeier, et al.
Blood
|
August 15, 1996
PU.1 (Spi-1) and C/EBP alpha regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells
L T Smith, S Hohaus, D A Gonzalez, et al.
Blood
|
June 15, 1995
Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support
R Haas, B Witt, R Möhle, et al.
Experimental Hematology
|
March 1, 1989
Enhanced myelopoiesis in long-term cultures of human bone marrow pretreated with recombinant granulocyte-macrophage colony-stimulating factor
R Haas, E Ogniben, S Kiesel, et al.
Behring Institute Mitteilungen
|
August 1, 1988
The effect of human recombinant GM-CSF on the myelopoiesis in a long-term bone marrow culture (LTBMC)
R Haas, S Kiesel, E Ogniben, et al.
Molecular and Cellular Biology
|
October 1, 1995
PU.1 (Spi-1) and C/EBP alpha regulate expression of the granulocyte-macrophage colony-stimulating factor receptor alpha gene
S Hohaus, M S Petrovick, M T Voso, et al.
Annals of Hematology
|
December 2, 2000
High-dose therapy with peripheral blood stem cell transplantation for patients with relapsed or refractory Hodgkin's disease: long-term outcome and prognostic factors
K Neben, S Hohaus, H Goldschmidt, et al.
Seminars in Oncology
|
May 13, 1998
Efficacy and toxicity of sequential high-dose therapy with peripheral blood stem cell support in patients with high-risk breast cancer
S Hohaus, D Wallwiener, S Martin, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 48) with videos related to
Sort By:
Page
of 5
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
September 26, 1997
Peripheral blood progenitor cell transplantation in multiple myeloma following high-dose melphalan-based therapy
H Goldschmidt, U Hegenbart, M Wallmeier, et al.
Blood
|
October 15, 1994
Monocyte chemoattractant protein-1 gene is expressed in activated neutrophils and retinoic acid-induced human myeloid cell lines
T C Burn, M S Petrovick, S Hohaus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1997
High-dose therapy with peripheral blood progenitor cell transplantation in multiple myeloma
H Goldschmidt, U Hegenbart, M Wallmeier, et al.
Blood
|
August 15, 1996
PU.1 (Spi-1) and C/EBP alpha regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells
L T Smith, S Hohaus, D A Gonzalez, et al.
Blood
|
June 15, 1995
Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support
R Haas, B Witt, R Möhle, et al.
Experimental Hematology
|
March 1, 1989
Enhanced myelopoiesis in long-term cultures of human bone marrow pretreated with recombinant granulocyte-macrophage colony-stimulating factor
R Haas, E Ogniben, S Kiesel, et al.
Behring Institute Mitteilungen
|
August 1, 1988
The effect of human recombinant GM-CSF on the myelopoiesis in a long-term bone marrow culture (LTBMC)
R Haas, S Kiesel, E Ogniben, et al.
Molecular and Cellular Biology
|
October 1, 1995
PU.1 (Spi-1) and C/EBP alpha regulate expression of the granulocyte-macrophage colony-stimulating factor receptor alpha gene
S Hohaus, M S Petrovick, M T Voso, et al.
Annals of Hematology
|
December 2, 2000
High-dose therapy with peripheral blood stem cell transplantation for patients with relapsed or refractory Hodgkin's disease: long-term outcome and prognostic factors
K Neben, S Hohaus, H Goldschmidt, et al.
Seminars in Oncology
|
May 13, 1998
Efficacy and toxicity of sequential high-dose therapy with peripheral blood stem cell support in patients with high-risk breast cancer
S Hohaus, D Wallwiener, S Martin, et al.
Page
of 5